GT Biopharma Receives FDA Clearance Of Investigational New Drug Application For GTB-5550 TriKE
Benzinga Newsdesk 9 months ago
BiotechNewsFDAGeneral
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
GTB-5550 Phase 1 dose escalation basket trial expected to initiate mid-2026Phase 1 protocol allows multiple solid tumor types known to express B7-H3Unaudited proforma cash balance as of January 31, 2026 of approximately
GTB-5550 Phase 1 dose escalation basket trial expected to initiate mid-2026
Phase 1 protocol allows multiple solid tumor types known to express B7-H3
Unaudited proforma cash balance as of January 31, 2026 of approximately $9 million anticipated to extend cash runway through Q4 2026